These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 23632004)
1. Role and mechanism of tissue plasminogen activator in venous wall fibrosis remodeling after deep venous thrombosis via the glycogen synthase kinase-3 beta signaling pathway. Yin M; Tian S; Huang X; Huang Y; Jiang M J Surg Res; 2013 Oct; 184(2):1182-95. PubMed ID: 23632004 [TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure. Lin CY; Hsu SC; Lee HS; Lin SH; Tsai CS; Huang SM; Shih CC; Hsu YJ J Vasc Surg; 2013 Feb; 57(2):475-85. PubMed ID: 23265586 [TBL] [Abstract][Full Text] [Related]
3. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model. Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463 [TBL] [Abstract][Full Text] [Related]
5. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor. Nicholl SM; Roztocil E; Davies MG J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933 [TBL] [Abstract][Full Text] [Related]
6. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis. Henke PK; Varma MR; Moaveni DK; Dewyer NA; Moore AJ; Lynch EM; Longo C; Deatrick CB; Kunkel SL; Upchurch GR; Wakefield TW Thromb Haemost; 2007 Nov; 98(5):1045-55. PubMed ID: 18000610 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of TRPM7 channels by angiotensin II triggers phenotypic switching of vascular smooth muscle cells of ascending aorta. Zhang Z; Wang M; Fan XH; Chen JH; Guan YY; Tang YB Circ Res; 2012 Oct; 111(9):1137-46. PubMed ID: 22896586 [TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator induces microglial inflammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors. Pineda D; Ampurdanés C; Medina MG; Serratosa J; Tusell JM; Saura J; Planas AM; Navarro P Glia; 2012 Apr; 60(4):526-40. PubMed ID: 22162045 [TBL] [Abstract][Full Text] [Related]
9. Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro. Matsuzaki S; Darcha C Hum Reprod; 2015 Jul; 30(7):1606-16. PubMed ID: 25976656 [TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor-1 promotes the proliferation and inhibits the apoptosis of pulmonary fibroblasts by Ca(2+) signaling. Zhang YP; Wang WL; Liu J; Li WB; Bai LL; Yuan YD; Song SX Thromb Res; 2013 Jan; 131(1):64-71. PubMed ID: 23021499 [TBL] [Abstract][Full Text] [Related]
11. tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway. Lin L; Bu G; Mars WM; Reeves WB; Tanaka S; Hu K Am J Pathol; 2010 Oct; 177(4):1687-96. PubMed ID: 20724593 [TBL] [Abstract][Full Text] [Related]
12. Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways. Cui RR; Mao DA; Yi L; Wang C; Zhang XX; Xie H; Wu XP; Liao XB; Zhou H; Meng JC; Yuan LQ; Liao EY Amino Acids; 2010 Nov; 39(5):1193-200. PubMed ID: 20495838 [TBL] [Abstract][Full Text] [Related]
13. The sphingomyelin/ceramide pathway is involved in ERK1/2 phosphorylation, cell proliferation, and uPAR overexpression induced by tissue-type plasminogen activator. Maupas-Schwalm F; Augé N; Robinet C; Cambus JP; Parsons SJ; Salvayre R; Nègre-Salvayre A FASEB J; 2004 Sep; 18(12):1398-400. PubMed ID: 15231724 [TBL] [Abstract][Full Text] [Related]
14. FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation. Giordano A; Romano S; Mallardo M; D'Angelillo A; Calì G; Corcione N; Ferraro P; Romano MF Cardiovasc Res; 2008 Aug; 79(3):519-26. PubMed ID: 18349138 [TBL] [Abstract][Full Text] [Related]
15. Elastic fibers reconstructed using adenovirus-mediated expression of tropoelastin and tested in the elastase model of abdominal aortic aneurysm in rats. Xiong J; Wang SM; Chen LH; Lin Y; Zhu YF; Ye CS J Vasc Surg; 2008 Oct; 48(4):965-73. PubMed ID: 18585885 [TBL] [Abstract][Full Text] [Related]
16. Insulin regulation of proliferation involves activation of AKT and ERK 1/2 signaling pathways in vascular smooth muscle cells. Isenovic ER; Fretaud M; Koricanac G; Sudar E; Velebit J; Dobutovic B; Marche P Exp Clin Endocrinol Diabetes; 2009 May; 117(5):214-9. PubMed ID: 19235132 [TBL] [Abstract][Full Text] [Related]
18. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling. Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126 [TBL] [Abstract][Full Text] [Related]
19. Cudraflavanone A, a flavonoid isolated from the root bark of Cudrania tricuspidata, inhibits vascular smooth muscle cell growth via an Akt-dependent pathway. Han HJ; Kim TJ; Jin YR; Hong SS; Hwang JH; Hwang BY; Lee KH; Park TK; Yun YP Planta Med; 2007 Sep; 73(11):1163-8. PubMed ID: 17713875 [TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis. Bonnet S; Paulin R; Sutendra G; Dromparis P; Roy M; Watson KO; Nagendran J; Haromy A; Dyck JR; Michelakis ED Circulation; 2009 Sep; 120(13):1231-40. PubMed ID: 19752325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]